Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
Raoof M, Whelan RL, Sullivan KM, Ruel C, Frankel PH, Cole SE, Tinsley R, Eng M, Fakih M, Chao J, Lim D, Woo Y, Paz IB, Lew M, Cristea M, Rodriguez-Rodriguez L, Fong Y, Thomas RM, Chang S, Deperalta D, Merchea A, Dellinger TH. Raoof M, et al. Among authors: cristea m. Ann Surg Oncol. 2023 Nov;30(12):7814-7824. doi: 10.1245/s10434-023-13941-2. Epub 2023 Jul 27. Ann Surg Oncol. 2023. PMID: 37501051 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 37598124
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial.
Nakamura B, Senguttuvan R, Ruel NH, Frankel PH, Yost SE, Cole S, Chang S, Jung A, Eng M, Tinsley R, Stewart D, Wang E, Cohen J, Villella J, Whelan RL, Merchea A, DePeralta DK, Cristea M, Wakabayashi MT, Raoof M, Dellinger TH. Nakamura B, et al. Among authors: cristea m. Front Oncol. 2024 Aug 1;14:1404936. doi: 10.3389/fonc.2024.1404936. eCollection 2024. Front Oncol. 2024. PMID: 39148906 Free PMC article.
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Liu JF, Xiong N, Wenham RM, Wahner-Hendrickson A, Armstrong DK, Chan N, O'Malley DM, Lee JM, Penson RT, Cristea MC, Abbruzzese JL, Matsuo K, Olawaiye AB, Barry WT, Cheng SC, Polak M, Swisher EM, Shapiro GI, Kohn EC, Ivy SP, Matulonis UA. Liu JF, et al. Among authors: cristea mc. Gynecol Oncol. 2024 Aug;187:105-112. doi: 10.1016/j.ygyno.2024.05.002. Epub 2024 May 17. Gynecol Oncol. 2024. PMID: 38759516 Clinical Trial.
223 results